Related Experiment Video
Updated: Oct 17, 2026

Murine Model for Parkinson's Disease: from 6-OH Dopamine Lesion to Behavioral Test
Published on: January 15, 2010
Pattern of dopaminergic loss in the striatum of humans with MPTP induced parkinsonism
B J Snow1, F J Vingerhoets, J W Langston
1The Neurodegenerative Disorders Centre, University of British Columbia, Vancouver, BC, Canada. bsnow@ahsl.co.nz
Objectives:
To examine the distribution of striatal dopaminergic function in humans with parkinsonism induced by 1-methyl-4-phenyl-1, 2,3,6-tetrahydropyridine (MPTP) to determine if there is a caudate-putamen gradient as is seen in idiopathic Parkinson's disease.
Methods:
We scanned nine humans exposed to MPTP with parkinsonism ranging from minimal to severe using [(18)F]fluorodopa (FD) and high resolution PET. The results were compared with those of 10 patients with Parkinson's disease and six normal subjects.
Results:
In the MPTP group there was an equal degree of reduction of dopaminergic function in the caudate and putamen. This was different from the greater putaminal than caudate loss in Parkinson's disease (p<0.001).
Conclusions:
Parkinson's disease is not caused by transient exposure to MPTP.
Related Concept Videos
Parkinson Disease ll: Pathophysiology
Parkinson Disease l: Introduction
Alterations in Muscle Tone lll
Neural Regulation

